We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Infrared Illuminator Aids in Phlebotomy

By LabMedica International staff writers
Posted on 03 Nov 2010
An illumination device has been introduced that will make the finding of veins or arteries much easier for drawing blood.

The new invention uses infrared light-emitting diode (LED) light that shines through a patient's limb and makes it possible to see the blood vessels on a screen instantaneously. More...
The device is used to navigate around the vascular system, so that the doctor or technician knows exactly where to insert the needle.

This practical system is called the VascuLuminator and was developed at the University Medical Center, (UMC; Utrecht, The Netherlands).

The system identifies the optimal puncture point, minimizes needle manipulation time and the procedure is successful nearly every time. The VascuLuminator can be operated with only one hand and the optimal contrast is obtained at 870 nm. When the device is used, the chance of unsuccessful phlebotomy drops dramatically.

The VascuLuminator is particularly suited for use in people with dark skin. Children with chronic diseases can also benefit, because they regularly undergo many procedures and the drawing of blood is often unsuccessful. Other beneficiaries are young infants because of their baby fat and obese people whose veins are also deeper down, and therefore more difficult to find. Those who have used it found it easy to manipulate, with only a small learning curve and were satisfied with the information on location, direction, and size of the blood vessels. The feasibility to visualize arteries in support of placing arterial lines has been performed.

Professor Ruud Verdaasdonk of UMC developed the devise and his doctoral student Natascha Cuper said, "This research has shown that by using the VascuLuminator, the percentage of unsuccessful punctures has dropped from 13% to 2%. It is also more efficient, because the doctor needs less time to insert the needle right the first time in a child who is likely to be afraid.” Pontes Medical, (Utrecht, the Netherlands) is helping develop the product in a cooperative venture with other Dutch medical centers.

Related Links:

University Medical Center, Utrecht
Pontes Medical



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.